Gotu Kola Dosage for Anxiety: Evidence, Timing & Safety

Feeling wired and looking for a calm herb that is not ashwagandha or kava? Gotu kola (Centella asiatica) is Ayurveda's "Herb of Longevity," traditionally used to calm the mind and sharpen clarity. But what does the human evidence actually say about gotu kola for anxiety — and what dose do the studies use? This guide breaks down the real trial doses, how the evidence stacks up, and who should skip it.

What Gotu Kola Is (and Its Anxiety-Relevant Compounds)

Gotu kola (Centella asiatica, not to be confused with bacopa, which is also sometimes called "brahmi") is a small leafy plant used for centuries in Ayurvedic and Traditional Chinese Medicine. LiverTox (the National Library of Medicine's drug-induced liver injury database) says the active ingredients are thought to be the pentacyclic triterpenoid glycosides — asiaticoside, centelloside, and madecassoside — plus their aglycones asiatic acid and madecassic acid.

In traditional medicine, gotu kola has been used for a wide range of conditions, from wound healing to venous insufficiency — and, relevant here, to calm the mind and support longevity. Preclinical studies suggest the triterpenoids have anxiolytic (anti-anxiety) properties in animal models, but as LiverTox emphasizes, "none of these properties have been proven in prospective, controlled trials in humans."

What the Human Evidence Says About Anxiety

Here is the honest picture: human evidence for gotu kola as an anxiolytic is thin — far thinner than for ashwagandha or bacopa. What exists:

The single-dose startle trial. A double-blind, placebo-controlled study by Bradwejn et al. (2000) gave 40 healthy volunteers a single 12 g oral dose of gotu kola (or placebo) and measured the acoustic startle response — a physiological marker of fear/anxiety. Compared to placebo, gotu kola significantly attenuated the peak startle amplitude at 30 and 60 minutes. Critically, it had no significant effect on self-rated mood, heart rate, or blood pressure. The authors called the findings "preliminary," noting that "it remains to be seen whether this herb has therapeutic efficacy in the treatment of anxiety syndromes" (PubMed PMID 11106141; single 12 g oral dose; N=20 gotu kola / N=20 placebo).

The GAD open-label study. Jana et al. (2010) tested a 70% hydro-ethanolic extract of Centella asiatica in 33 participants with generalized anxiety disorder. Subjects received 500 mg capsules twice daily after meals for 60 days, and scores were assessed at baseline, day 30, and day 60. The study reported significant (p<0.01) attenuation of anxiety-related symptoms, stress, and correlated depression, plus improved willingness for adjustment and cognition. However, this was an open-label, uncontrolled study — without a placebo group, the large placebo response typical of anxiety trials cannot be ruled out. Treat these results as suggestive, not definitive.

Preclinical work. Multiple animal studies (elevated plus maze, acoustic startle, chronic-stress models) support an anxiolytic effect. Pure asiaticoside produced anxiolytic effects in the elevated plus maze in rats without sedation (Wijeweera et al., 2006), and the standardized extract ECa 233 (≥80% triterpenoids) reduced anxiety-like behavior in chronically immobilized mice, with madecassoside and asiaticoside reproducing the effect (Tantisira et al., 2012). Animal data does not guarantee human efficacy, but it gives the mechanism plausibility.

The bottom line: There is no well-powered, placebo-controlled trial of daily gotu kola dosing for clinical anxiety. If anxiety is the goal, ashwagandha and bacopa have substantially stronger human evidence. Gotu kola's anxiety use is a "traditionally used + biologically plausible + one intriguing acute-dose trial" story — worth trying for mild stress, not a substitute for proven approaches in GAD.

Gotu Kola Dosage for Anxiety: What the Studies Used

Because there is no established clinical protocol for anxiety, dosing has to be triangulated from the trials and traditional/monograph ranges:

A practical starting approach (not a clinical recommendation): 300–500 mg of standardized extract once or twice daily, with a stated triterpene/asiaticoside content on the label, taken with food. The Jana study's 500 mg twice daily for 60 days is the only repeated-dose anxiety data point — but remember it was uncontrolled. (Systematic reviews of controlled anxiety trials, e.g. Pittler & Ernst, list only the single-dose Bradwejn trial as placebo-controlled evidence for gotu kola; no controlled repeated-dose trial in an anxiety population has been published.)

Standardization: What to Look For on the Label

Unlike bacopa (with its ≥55% bacosides benchmark), gotu kola has no single dominant consumer standardization — but the vascular trials use TTFCA (total triterpenic fraction of Centella asiatica) standardized for asiaticoside/madecassoside content. On labels, look for:

• Standardized to X% triterpenes / asiaticoside / madecassoside — a numbered standardization is always preferable to "whole herb powder."
• "Total triterpenic fraction" (TTFCA) — the clinical-trial form for vascular indications.
• Avoid products that list only "gotu kola (leaf) 500 mg" with no standardization claim; potency varies wildly.

How Long Until It Works

There is no trial timeline for chronic anxiety relief because no controlled repeated-dose anxiety trial exists. What we know:

• Acute effect: The Bradwejn trial showed measurable startle attenuation at 30–60 minutes after a single large dose — a same-day physiological signal, not a self-reported mood change.
• Repeated dosing: The Jana study measured improvements at day 30 and day 60 — but without a control group, these timelines reflect expectations as much as pharmacology.
• Traditional use and the site's own guidance: Not for long-term continuous use without breaks — see Safety below.

A reasonable expectation frame: if you are trying gotu kola for everyday stress, give it 4–6 weeks of consistent daily use and judge by whether your perceived stress and sleep quality improve — objective anxiety-disorder symptoms warrant professional care, not self-trials.

Gotu Kola vs Ashwagandha vs Bacopa for Anxiety

Gotu kola may make sense as an add-on calm for people who want variety in their stress routine — but for primary anxiety support, ashwagandha's trial record is in a different league.

Safety: Who Should Avoid It

Gotu kola is not a "take forever" herb:

• Liver risk with prolonged use. Rare cases of acute liver injury with jaundice have been reported after 3–8 weeks of gotu kola use — LiverTox calls hepatotoxicity "very rare" (likelihood score C: probable rare cause), noting injuries resolved within 1–2 months of stopping. No clinical trial has established a safe maximum continuous duration, so the >8-week caution is precautionary, not trial-derived (consumer monographs suggest 2–6 weeks at a time with a 2-week break; published case reports span 3–8 weeks of use). Conservative approach: 6–8 weeks on, 2+ weeks off.
• Pregnancy and conception. Avoid oral use if pregnant or trying to conceive. Drugs.com's clinical overview (citing Ernst 2002) advises avoiding gotu kola in pregnancy and lactation due to possible emmenagogue effects; oral safety data in pregnancy are insufficient, and crude extracts showed antifertility effects in female mice (preclinical).
• Sedation/drowsiness. May cause drowsiness; combine carefully with other sedatives (valerian, kava, alcohol, sleep medications).
• Photosensitivity and skin reactions. High doses can cause photosensitivity; topical use in excess can irritate skin.
• Surgery. Consumer drug references advise stopping gotu kola at least 2 weeks before surgery (Drugs.com) — this is a precaution based on possible sedative effects plus in-vitro antiplatelet activity of unknown clinical significance, not trial evidence. Confirm with your surgeon.
• Medication interactions. May increase drowsiness with sedatives (valerian, kava, alcohol, sleep medications); avoid combining with other hepatotoxic drugs. A standardized extract (ECa 233) inhibited CYP3A4, CYP2C19, and CYP2B6 in an in-vitro study using human CYP isoforms — but not CYP1A2, 2C9, 2D6, or 2E1 — and the clinical relevance is unknown (Seeka et al., 2012). Discuss with your clinician if you take medications metabolized by these pathways (including some statins).

Dosage Summary Table

📢 Disclaimer: This information is for educational purposes only and is not medical advice. Always consult a qualified healthcare professional before starting any new supplement. Sources are linked for verification.

Explore the Full Remedy Database

Browse 500+ organic alternatives for health, wellness, and natural living.